BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 29653744)

  • 21. Spalt-like transcription factor 4 as a potential diagnostic and prognostic marker of colorectal cancer.
    Wu HK; Liu C; Fan XX; Wang H; Zhou L
    Cancer Biomark; 2017 Aug; 20(2):191-198. PubMed ID: 28869451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical significance of microRNA-21 as a biomarker in each Dukes' stage of colorectal cancer.
    Fukushima Y; Iinuma H; Tsukamoto M; Matsuda K; Hashiguchi Y
    Oncol Rep; 2015 Feb; 33(2):573-82. PubMed ID: 25421755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The high expression of long non-coding RNA PANDAR indicates a poor prognosis for colorectal cancer and promotes metastasis by EMT pathway.
    Lu M; Liu Z; Li B; Wang G; Li D; Zhu Y
    J Cancer Res Clin Oncol; 2017 Jan; 143(1):71-81. PubMed ID: 27629879
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GATA binding protein 2 overexpression is associated with poor prognosis in KRAS mutant colorectal cancer.
    Xu K; Wang J; Gao J; Di J; Jiang B; Chen L; Wang Z; Wang A; Wu F; Wu W; Shen L; Su X
    Oncol Rep; 2016 Sep; 36(3):1672-8. PubMed ID: 27460045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of IRF-2 expression in colorectal cancer.
    Mei Z; Wang G; Liang Z; Cui A; Xu A; Liu Y; Liu C; Yang Y; Cui L
    Oncotarget; 2017 Jun; 8(24):38969-38977. PubMed ID: 28465494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated Expression of DLG1 Is Associated with Poor Prognosis in Patients with Colorectal Cancer.
    Zhu GD; OuYang S; Liu F; Zhu ZG; Jiang FN; Zhang B
    Ann Clin Lab Sci; 2017 Nov; 47(6):657-662. PubMed ID: 29263038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of TUSC3 and its prognostic significance in colorectal cancer.
    Zhu YF; Dong M
    Pathol Res Pract; 2018 Sep; 214(9):1497-1503. PubMed ID: 30115537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lysosomal acid phosphatase 2 is an unfavorable prognostic factor but is associated with better survival in stage II colorectal cancer patients receiving chemotherapy.
    Lee YC; Su CY; Lin YF; Lin CM; Fang CY; Lin YK; Hsiao M; Chen CL
    Oncotarget; 2017 Feb; 8(7):12120-12132. PubMed ID: 28076332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of ZNF148 in different developing stages of colorectal cancer and its prognostic value: a large Chinese study based on tissue microarray.
    Gao XH; Liu QZ; Chang W; Xu XD; Du Y; Han Y; Liu Y; Yu ZQ; Zuo ZG; Xing JJ; Cao G; Fu CG
    Cancer; 2013 Jun; 119(12):2212-22. PubMed ID: 23576061
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic Correlation Between MFG-E8 Expression Level and Colorectal Cancer.
    Jia M; Yao H; Chen C; Wang Y; Wang H; Cui T; Zhu J
    Arch Med Res; 2017 Apr; 48(3):270-275. PubMed ID: 28923329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased expression of Rab5A predicts metastasis and poor prognosis in colorectal cancer patients.
    Yu MH; Luo Y; Qin SL; Zhong M
    Int J Clin Exp Pathol; 2015; 8(6):6974-80. PubMed ID: 26261586
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased expression of semaphorin 3D is associated with genesis and development in colorectal cancer.
    Wang Z; Ding M; Qian N; Song B; Yu J; Tang J; Wang J
    World J Surg Oncol; 2017 Mar; 15(1):67. PubMed ID: 28320475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic role of nucleophosmin in colorectal carcinomas.
    Yang YF; Zhang XY; Yang M; He ZH; Peng NF; Xie SR; Xie YF
    Asian Pac J Cancer Prev; 2014; 15(5):2021-6. PubMed ID: 24716928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic correlation between MTA2 expression level and colorectal cancer.
    Ding W; Hu W; Yang H; Ying T; Tian Y
    Int J Clin Exp Pathol; 2015; 8(6):7173-80. PubMed ID: 26261611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High Rab27A expression indicates favorable prognosis in CRC.
    Shi C; Yang X; Ni Y; Hou N; Xu L; Zhan F; Zhu H; Xiong L; Chen P
    Diagn Pathol; 2015 Jun; 10():68. PubMed ID: 26070933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gab2 is a novel prognostic factor for colorectal cancer patients.
    Ding C; Luo J; Yu W; Gao S; Yang L; Chen C; Feng J
    Int J Clin Exp Pathol; 2015; 8(3):2779-86. PubMed ID: 26045784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p42.3: a promising biomarker for the progression and prognosis of human colorectal cancer.
    Yuan XS; Zhang Y; Guan XY; Dong B; Zhao M; Mao LL; Lu YY; Tian XY; Hao CY
    J Cancer Res Clin Oncol; 2013 Jul; 139(7):1211-20. PubMed ID: 23576022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of Arginase-1 is an indicator of poor prognosis in patients with colorectal cancer.
    Ma Z; Lian J; Yang M; Wuyang J; Zhao C; Chen W; Liu C; Zhao Q; Lou C; Han J; Zhang Y
    Pathol Res Pract; 2019 Jun; 215(6):152383. PubMed ID: 30890279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gremlin1 expression associates with serrated pathway and favourable prognosis in colorectal cancer.
    Pelli A; Väyrynen JP; Klintrup K; Mäkelä J; Mäkinen MJ; Tuomisto A; Karttunen TJ
    Histopathology; 2016 Nov; 69(5):831-838. PubMed ID: 27257976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of Aldehyde Dehydrogenase 1A1 (ALDH1A1) as a Prognostic Biomarker in Colorectal Cancer Using Immunohistochemistry.
    Yang W; Wang Y; Wang W; Chen Z; Bai G
    Med Sci Monit; 2018 May; 24():2864-2872. PubMed ID: 29748529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.